Risk Factors for Endocrine Complications in Transfusion-Dependent Thalassemia Patients on Chelation Therapy With Deferasirox
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk Factors for Endocrine Complications in Transfusion-Dependent Thalassemia Patients on Chelation Therapy With Deferasirox: A Risk Assessment Study From a Multicentre Nation-Wide Cohort
Haematologica 2021 Jan 07;[EPub Ahead of Print], M Casale, GL Forni, E Cassinerio, D Pasquali, R Origa, M Serra, S Campisi, A Peluso, R Renni, A Cattoni, E De Michele, M Allò, M Poggi, F Ferrara, R Di Concilio, F Sportelli, A Quarta, MC Putti, LD Notarangelo, A Sau, S Ladogana, I Tartaglione, S Picariello, A Marcon, P Sturiale, D Roberti, AI Lazzarino, S PerrottaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.